Clinical Trials
Clinical Trials
Monday, April 27, 2026 12:00 AM
Conditions: Head and Neck Squamous Cell Carcinoma; HPV-Negative Squamous Cell Carcinoma Interventions: Radiation: Hypofractionated Stereotactic Body Radiotherapy (SBRT); Biological: Pembrolizumab; Drug: Ficerafusp alfa Sponsors: Washington ...
Friday, April 24, 2026 12:00 AM
Conditions: TBI (Traumatic Brain Injury) Interventions: Behavioral: Social intervention study for TBI survivors Sponsors: Washington University School of Medicine; American Occupational Therapy Foundation Not yet recruiting
24VA021; VATCH Trametinib for Ras/MAPK Pathway VAs
Friday, April 24, 2026 12:00 AM
Conditions: Ras/MAPK Pathway Vascular Anomalies; Vascular Anomalies; Vascular Anomaly Interventions: Drug: Trametinib Sponsors: Children's Hospital of Philadelphia; Novartis; CaNVAS (Consortium of Investigators of Vascular Anomalies); ...
Overcoming Racial Disparities in Screening Mammography
Thursday, April 23, 2026 12:00 AM
Conditions: Breast Cancer; Cancer of the Breast Interventions: Other: Appointment mail reminder; Other: Telephone counseling; Other: Digital navigation video; Other: Automated phone call Sponsors: Washington University School of Medicine; ...
24VA022; VATCH Alpelisib for TIE2/PIK3CA Pathway VAs
Wednesday, April 22, 2026 12:00 AM
Conditions: Vascular Anomalies; Vascular Anomaly; TIE2/PIK3CA Pathway Driven Vascular Anomalies Interventions: Drug: alpelisib (BYL719) Sponsors: Children's Hospital of Philadelphia; Novartis; CaNVAS (Consortium of Investigators of Vascular ...
DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer
Wednesday, April 22, 2026 12:00 AM
Conditions: Small-cell Lung Cancer; Small Cell Lung Cancer Extensive Stage Interventions: Drug: DSP-0390; Drug: Atezolizumab Sponsors: Washington University School of Medicine; Sumitomo Pharma America, Inc. Not yet recruiting
Thursday, April 16, 2026 12:00 AM
Conditions: Type B Aortic Dissection Interventions: Device: Auricular Vagus Nerve Stimulator; Device: 3D Printed Earpiece Sponsors: Washington University School of Medicine Not yet recruiting
Longitudinal Tracking of Bone Marrow Plasma Cell Responses to Licensed Human Vaccines
Wednesday, April 22, 2026 12:00 AM
Conditions: Immunology; Healthy Adults Interventions: Biological: trivalent inactivated influenza vaccine (TIV); Biological: nonavalent HPV vaccine (HPV); Biological: hepatitis A (HAV) vaccines; Biological: tetanus, diphtheria and acellular ...
